First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report. - Wang K; Taslic CA; de Groot P; Parma MA; Paula AG; Caranto M; Shah K; Bose M; Ruoff C; Karacosta LG; Byers LA; Gay CM; et al. (JTO clinical and research reports, 2025)